OTC:INLB Item 9 Labs (INLB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Item 9 Labs Stock (OTC:INLB) 30 days 90 days 365 days Advanced Chart Get Item 9 Labs alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume13.46 million shsMarket Capitalization$70,000.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewItem 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.Read More… Receive INLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Item 9 Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address INLB Stock News HeadlinesItem 9 Labs CorpJanuary 4, 2024 | morningstar.comItem 9 Labs Corp. Retains Sharp Capital Advisors to Facilitate a Sale of the BusinessDecember 19, 2023 | finance.yahoo.comPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. Today, he's a multimillionaire tech investor and entrepreneur. And he says as soon as May 31, two of the most powerful technologies of all time are set to converge, creating more millionaires in the coming years than anything else on the planet.May 24, 2025 | Stansberry Research (Ad)'The Jewel In The Crown': How Data Is Shaping Cannabis Retail, 'Customers Are Key', Says Item 9 Labs CEOAugust 11, 2023 | markets.businessinsider.comINLB Item 9 Labs Corp.August 9, 2023 | seekingalpha.com'We're Owned By People From The Community," Says Item 9 Labs Corp CEO On Its Franchise ModelAugust 3, 2023 | benzinga.comItem 9 Labs announces restructuring to cut costsMay 23, 2023 | msn.comItem 9 Labs Corp. Executes Major Restructuring to Pave the Way to ProfitabilityMay 23, 2023 | finance.yahoo.comSee More Headlines INLB Stock Analysis - Frequently Asked Questions How were Item 9 Labs' earnings last quarter? Item 9 Labs Corp. (OTC:INLB) posted its quarterly earnings results on Monday, May, 16th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. How do I buy shares of Item 9 Labs? Shares of INLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Item 9 Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Item 9 Labs investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), PayPal (PYPL), Teladoc Health (TDOC) and Adobe (ADBE). Company Calendar Last Earnings5/16/2022Today5/24/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Dental equipment & supplies Sub-IndustryMedical Equipment Current SymbolOTC:INLB CIK1500123 Webwww.item9labscorp.com Phone833-867-6337FaxN/AEmployees100Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$21.76 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares701,919,000Free Float562,848,000Market Cap$70,000.00 OptionableNot Optionable Beta0.77 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (OTC:INLB) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Item 9 Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Item 9 Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.